Olive’s Kitchen Turkey Tail Dog Mushroom Powder: Veterinary Product Profile

Olive's Kitchen Dog Mushroom Powder - Turkey Tail is a named branded product for Dogs; manufacturer positioning is kept separate from independent clinical and regulatory evidence.

oral powder in 90 g and 250 g presentations. Intended species: Dogs.

The current official page lists Turkey Tail mushroom powder as the only ingredient. The page also uses the phrase mushroom extract in direction text but does not provide an extraction ratio, fruiting-body or mycelium specification, substrate information, quantitative beta-glucan analysis, or inactive ingredients. It should therefore be described conservatively as powder unless the physical label documents more.

Olive's Kitchen markets the product for immune, digestive, energy, healthy-ageing, and general wellbeing support in dogs. The page contains broad mushroom-health statements but is not evidence that the powder treats cancer. The Directory should preserve the product's actual wellness scope rather than inflate it because Turkey Tail is often marketed in oncology contexts.

May be discussed only as supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.

Define a modest supportive objective, baseline, review date, adverse-event plan, and stopping rule with the veterinarian.

Bring the current label, lot, full ingredient panel, country version, complete diet, medicines, and supplements to the treating veterinarian.

The official page supports current product identity, brand, species, package sizes, and the single stated ingredient. No controlled canine oncology trial of this finished powder was identified. The 2012 pilot concerned a different purified PSP product and does not establish equivalence to an unspecified Turkey Tail powder or extract.

Review mushroom allergy, gastrointestinal tolerance, autoimmune disease, immunosuppressive or immune-directed therapy, anticoagulants, surgery, pregnancy, liver or kidney disease, and other mushroom products. Powder, extract, mycelium, and fruiting-body products are not interchangeable. The manufacturer should clarify the extract wording, source material, analytical testing, and contaminant controls.

No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.

Sold in New Zealand as a dog supplement or oral nutritional product. MPI rules for oral nutritional compounds depend on product conditions and claims. No New Zealand veterinary-medicine authorisation for cancer treatment was verified, and the product should not be described as an approved anticancer medicine.

New Zealand

Record whether the 90 g or 250 g pack was supplied, lot, expiry, full label, start date, diet, medicines, and supportive objective. Track appetite, vomiting, diarrhoea, stool, itching, swelling, energy, weight, bleeding or bruising, and prescribed-treatment adherence. Objective oncology assessment continues independently.